ObsEva Overview
- Year Founded
-
2012
- Status
-
Out of Business
- Employees
-
6
- Latest Deal Type
-
Liquidation
ObsEva General Information
Description
ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The Company operates in one segment, which is the research and development of women's reproductive, health, and pregnancy therapeutics. It includes advancing a development program for Nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization (IVF). Geographically, the majority is from Switzerland.
Contact Information
Website
www.obseva.comCorporate Office
- Chemin des Aulx, 12
- Plan-les-Ouates
- 1228 Geneva
- Switzerland
Corporate Office
- Chemin des Aulx, 12
- Plan-les-Ouates
- 1228 Geneva
- Switzerland
ObsEva Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Bankruptcy: Liquidation | Completed | Generating Revenue | ||||
| 10. Debt - General | 12-Oct-2021 | Completed | Generating Revenue | |||
| 9. 2PO | 03-Sep-2020 | Cancelled | Generating Revenue | |||
| 8. PIPE | 03-Sep-2020 | Completed | Generating Revenue | |||
| 7. General Corporate Purpose | 08-Aug-2019 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Open Market | 31-Dec-2017 | Completed | Generating Revenue | |||
| 5. PIPE | 13-Oct-2017 | Completed | Generating Revenue | |||
| 4. IPO | 26-Jan-2017 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 23-Nov-2015 | $60.5M | $95.1M | Completed | Generating Revenue | |
| 2. Early Stage VC (Series A) | 29-Aug-2013 | $34.6M | $34.6M | Completed | Startup |
ObsEva Comparisons
Industry
Financing
Details
ObsEva Competitors (13)
One of ObsEva’s 13 competitors is Idorsia Pharmaceuticals, a Corporation company based in Allschwil, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Idorsia Pharmaceuticals | Corporation | Allschwil, Switzerland | ||||
| Aclaris Therapeutics | Formerly VC-backed | Wayne, PA | ||||
| Roivant Sciences | Formerly PE-Backed | New York, NY | ||||
| Adienne | Corporation | Lugano, Switzerland | ||||
| Evotec | Formerly PE-Backed | Hamburg, Germany |
ObsEva Patents
ObsEva Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022101495-A1 | Compositions and methods for the treatment or prevention of preterm labor | Inactive | 16-Nov-2020 | ||
| AU-2021218895-A1 | Biomarkers for oxytocin receptor antagonist therapy | Inactive | 10-Feb-2020 | ||
| CA-3167121-A1 | Biomarkers for oxytocin receptor antagonist therapy | Pending | 10-Feb-2020 | ||
| EP-4103750-A1 | Biomarkers for oxytocin receptor antagonist therapy | Inactive | 10-Feb-2020 | ||
| US-20230102503-A1 | Biomarkers for oxytocin receptor antagonist therapy | Inactive | 10-Feb-2020 | C12Q1/6883 |
ObsEva Signals
ObsEva ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
ObsEva FAQs
-
When was ObsEva founded?
ObsEva was founded in 2012.
-
Where is ObsEva headquartered?
ObsEva is headquartered in Geneva, Switzerland.
-
What is the size of ObsEva?
ObsEva has 6 total employees.
-
What industry is ObsEva in?
ObsEva’s primary industry is Drug Discovery.
-
Is ObsEva a private or public company?
ObsEva is a Private company.
-
What is ObsEva’s current revenue?
The current revenue for ObsEva is .
-
How much funding has ObsEva raised over time?
ObsEva has raised $384M.
-
Who are ObsEva’s competitors?
Idorsia Pharmaceuticals, Aclaris Therapeutics, Roivant Sciences, Adienne, and Evotec are some of the 13 competitors of ObsEva.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process